2.75 (-%)
As of Nov 22, 2024
Source:
Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on the development of Aramchol. Historically, we have focused almost exclusively on developing Aramchol for the treatment of liver disease. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide.
Country | Israel |
Headquarters | tel aviv |
Phone Number | 97236938448 |
Industry | manufacturing |
CEO | Allen Baharaff |
Website | galmedpharma.com |